Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Burlington/Dingell staffer meeting

This article was originally published in The Gray Sheet

Executive Summary

Device center Director-designate Bruce Burlington meets with Hill staffer Claudia Beville on Feb. 9. Beville, who works on Rep. John Dingell's (D-Mich.) Energy and Commerce oversight subcommittee, also met with device center managers on Feb. 1 to discuss remarks she gave at the Food and Drug Law Institute's annual conference in December. At the conference, Beville discussed her perceptions of the major problems facing the device center ("The Gray Sheet" Dec. 14, p. 4).

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000186

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel